A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer

Trial Profile

A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2016

At a glance

  • Drugs Indoximod (Primary) ; Docetaxel; Paclitaxel
  • Indications Advanced breast cancer; Male breast cancer
  • Focus Therapeutic Use
  • Sponsors NewLink Genetics Corporation
  • Most Recent Events

    • 12 Dec 2015 Preliminary results (n=65) presented at the 38th Annual San Antonio Breast Cancer Symposium.
    • 10 Dec 2015 Preliminary results published in a NewLink Genetics Corporation media release.
    • 10 Dec 2015 Status changed from recruiting to active, no longer recruiting according to a NewLink Genetics Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top